Find information on thousands of medical conditions and prescription drugs.

Dostinex

more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Introduction and Phrmacology

Cabergoline (brand names Dostinex® and Cabaser®), an ergot-derivative, is a potent dopamine receptor agonist on D2-Receptors. It also acts on dopamine-receptors in lactophilic hypothalamus cells and causes thereby a suppression of the prolactin-production in pituitary gland.

Pharmacokinetics

Following an oral single dose the drug is resorbed within 0.5 to 4 hours from the GI-Tract with considerable interindividual differences. Meals do not alter the absorption characteristic. Human bioavailibility was not determined, because the drug is intended for oral use only. In mice and rats the absolute bioavailability was 30 and 63%, respectively. Cabergoline is rapidly and to a great extend metabolized in the liver and excreted in bile and far less in urine. All metabolites are less active than the parental drug or inactive. The human elimination halflife is estimated to be 63 to 68 hours in patients with M. Parkinson and 79 to 115 hours in patients with pituitary tumors.

Carcinogenity

In rodents a dose dependent increase in malignant tumors has been found. They are thought to be species-specific. No clinical data exists on carcinogenity in humans.

Uses

  • Monotherapy of Morbus Parkinson in the early phase.
  • Combination therapy of Morbus Parkinson in the progressive phase together with levodopa and a decarboxylase-inhibitor like carbidopa.
  • Adjunctive therapy of prolactin-producing tumors of the pituitary gland (microprolactinomes).
  • In some countries also : ablactation and dysfunctions associated with hyperprolactinemia (amenorrhea, oligomenorrhea, anovulation, und galactorrhea).

Off-Label/Recreational Uses

It has at times been used as an adjunct to SSRI antidepressants as there is some evidence that it counteracts certain side effects of those drugs such as reduced libido and anorgasmia. It also has been suggested online that it has a possible recreational use in reducing or eliminating the male refractory period.

Contraindications and Precautions

  • Hypersensitivity to ergot-derivatives
  • Pediatric Patients (no clinical experience)
  • Severely impaired liver function or cholestasis
  • Comedication with drugs metabolized mainly by CYP P450 such as erythromycin and ketoconazole, because increased plasma levels of cabergoline may result.
  • Cautions : severe cardiovascular disease, Raynaud's Syndrome, gastroduodenal ulcers, active gastrointestinal bleeding, hypotension.

Pregnancy and Lactation

  • Pregnancy : Approximately 100 female patients became pregnant under therapy with cabergoline for hyperprolactinemic conditions. The incidence of spontanous aborts and congenital abnormalities was comparable to nontreated patients. Nonetheless womem, wishing to become pregnant, should wait a safety period of 4 weeks after discontinuation of cabergoline. Patients becoming pregant under therapy should terminate cabergoline immediately, if possible.
  • Lactation : In rats cabergoline was found in the maternal milk. Since it is not known, if this effect is also seen in humans, lactating women should not be treated.

Read more at Wikipedia.org


[List your site here Free!]


Diary from a week in practice
From American Family Physician, 3/1/04 by Tony Miksanek

Monday

If he had his druthers, Andy Zeno would spend his every waking moment fishing. Three days earlier, the 71-year-old man was reeling in a fish when he suddenly felt extremely weak. He lay on the beach for over an hour, hoping the sensation would pass. Somehow, he managed to drive himself home. "Why have you waited so long to get checked out?" I asked. "I thought I just overdid it," he said. Besides feeling "drained, "Mr. Zeno's only other symptom was upper back pain. An electrocardiogram showed prominent Q waves in leads II, III, and AVF. Laboratory results were obtained, and one value stood out: troponin I more than 50 ng per mL. He had experienced an acute inferior wall myocardial infarction. Mr. Zeno could not believe he had actually had a heart attack. "My chest never hurt at all." I admitted him to the hospital, and he underwent cardiac catheterization studies. The findings included a 95 percent stenosis of the ostial right coronary artery (RCA), 60 percent stenosis of the mid RCA, and 100 percent stenosis of the first obtuse marginal branch. Revascularization of the RCA with angioplasty and stent placement was successful. "Who would have thought that fishing could be hazardous to your health?" Mr. Zeno thought out loud the morning of his discharge. "The fish," I deadpanned.

Tuesday

While performing breast self-examination, Peggy noticed some milky discharge from her right nipple. Years earlier, the 55-year-old woman had undergone a total abdominal hysterectomy with bilateral salpingo-oophorectomy for endometriosis. She had discontinued hormone therapy about a year ago. I could not detect any abnormalities when I examined her breasts--no area of tenderness, no lump, no nipple inversion. In fact, no discharge could be expressed from either nipple on that day. A recent screening mammogram was negative. Thyroid function studies were normal, but the prolactin level was markedly elevated, at 131 ng per mL. Peggy was not taking any medications associated with hyperprolactinemia. She denied having headaches or any visual field problems. A magnetic resonance image (MRI) of the pituitary gland demonstrated an 8-mm microadenoma without mass effect on the optic chiasm. Cabergoline (Dostinex), 0.5 mg twice a week, was prescribed. Two months later, Peggy's prolactin level was back to normal, at 2 ng per mL, and she reported no further breast discharge.We'll plan on repeating the MRI scan later this year, and we'll keep close tabs on her prolactin level as well.

Wednesday

"My ear hurts again. "Hannah gently tugged on her left earlobe so I wouldn't mistake which one was troubling her. The canal was totally plugged with cerumen. "Can you hear anything with your left ear?" I asked her. She studied my face and then shrieked, "Not wax, again!" Today was the 12-year-old girl's third visit to my office in the past 11 months for the same problem. "This left ear must be your Achilles' heel," I told her. "Huh?" she replied. Hannah had no idea what I was talking about. So, as I cleaned her ear, I recounted the tale of Achilles. She remained motionless throughout my description of his exploits and invulnerability. "Because Achilles' mother had held him by his foot when she dipped him into the River Styx, the only part of his body that could ever be injured was his heel." I finished my rendition of the tale at exactly the same moment I extracted the last chunk of wax from Hannah's ear. "Clean as a whistle," I proclaimed. We once again reviewed methods of preventing cerumen build-up. As they exited the examination room, I overheard Hannah ask her mom, "What does a foot have to do with my ear? "Hannah's mother shook her head and answered, "I was wondering the same thing myself." It sounds like a clean ear beats a good story any day.

Thursday

Some news is hard to swallow. Four years ago, Lyle was at the office for a routine physical examination. "I'm going to retire next year," he announced, "and I want to be sure I'm in tip-top shape." The 64-year-old man looked fit and took no medication. He enjoyed a beer once in awhile and had quit smoking cigarettes a few years earlier. "It's probably no big deal, but lately I've noticed some trouble swallowing." Lyle had been experiencing substernal dysphagia for a couple of months. He also described occasional heartburn, but denied any involuntary weight loss, hematemesis, or melena. I recommended omeprazole (Prilosec) but decided he needed an endoscopic evaluation. The results weren't what Lyle planned on--poorly differentiated Stage III adenocarcinoma of the distal esophagus. He received radiation therapy and chemotherapy; was given cisplatin, 5-fluorouracil, and gemcitabine; and had an esophagectomy. Postoperatively, he developed pneumonia and a pulmonary embolism. Today, Lyle reminds me what a lucky man he is. "If you hadn't diagnosed that cancer, I might not be here now. Besides, I feel like a million. "His most recent carcinoembryonic antigen level is 2.4 ng per mL. Computed tomographic scans of the chest and abdomen show no evidence of tumor recurrence. Lyle is indeed a fortunate man, as well as a wise one.

Friday

Do you ever feel that getting some patients to heed your medical advice is downright back breaking? Consider Sophie, a 70-year-old retired nurse who finally agreed to have a dual-energy x-ray absorptiometry scan performed, after I had been recommending the test for years. It documented a T score of -4.10 at the radius and -2.85 at the L2-L4 level. I prescribed alendronate (Fosamax) for her osteoporosis, but she stopped taking it because it upset her stomach. She refused any alternative treatment other than calcium and vitamin D supplements, and exercise. Recently, Sophie developed severe pain in the middle of her back. She didn't recall injuring herself, but she had been lifting heavy boxes. X-rays demonstrated compression fractures of T-7 and T-9, with 60 and 80 percent loss of vertebral height, respectively. She underwent vertebral kyphoplasty and had a dramatic reduction in her pain almost immediately. Despite her nursing background (or perhaps because of it), she was leery of taking prescription medicine. The compression fractures, however, had taught Sophie a painful lesson about the importance of addressing her osteoporosis. We compromised on calcitonin nasal spray (Miacalcin). "I suspect your nose is less sensitive than your stomach," I offered. "And if the spray bothers me, then what?" Sophie asked. She didn't wait for my response and proceeded to answer her own question. "I guess it's the glue factory."

Saturday/Sunday

"You've either become extremely accident-prone or you're just plain clumsy," I joked with Molly. "Which is it?" I had just finished applying a cast to her fractured wrist. "How 'bout both?" she chuckled. I noticed that the quality of her voice had changed. Molly, a single woman in her 30s, enjoyed clowning around but she had racked up a disturbing number of injuries in the past 18 months: left rib fractures, broken toe, bruised lower back, right wrist fracture, and a large contusion of the hip. "I guess my balance is bad," she decided. "Sometimes my legs feel stuck, and I can't help but fall." She had a mild tremor and dysmetria on finger to nose to finger testing. Her gait was unsteady, and her speech had become hesitant and monotonous. A referral to a neurologist generated a diagnosis of cerebellar degeneration, which was likely the result of an inherited genetic mutation. She was placed on propranolol (Inderal LA) for her tremor and now receives botulinum toxin injections for her laryngeal dystonia. "Hey Doc," Molly slowly stammers, "I don't know 'bout my voice, but those Botox shots are sure helping my wrinkles." She deliberately massages her neck for effect. I accidentally drop my pen while laughing. Molly stares at me and then offers a warning: "You better hope this cerebellar condition I have isn't contagious." Fortunately it isn't, but her joie de vivre certainly is.

Dr. Tony Miksanek has been a family physician for more than 20 years. Most of that time has been in solo private practice in Benton, a town of about 7,000 people in rural southern Illinois.

Address correspondence to Tony Miksanek, M.D., 712 Old Orchard Dr., Benton, IL 62812. In order to preserve patient confidentiality, the patients' names and identifying characteristics have been changed in each scenario.

COPYRIGHT 2004 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Dostinex
Home Contact Resources Exchange Links ebay